Pharmaceuticals

Managing IP Rankings 2023
Carpmaels ranked tier 1 for patent disputes and patent prosecution
Read More
22
Sep
2023
Carpmaels engages with EPO consultation on Rules of Procedure of Boards of Appeal
The EPO is proposing revisions to the Rules of Procedure of the Boards of Appeal, but the changes could place undue time pressure on parties
Read More
19
Sep
2023
Potential referral to the EPO Enlarged Board on description amendments
Clarity at last? An EPO Board of Appeal has suggested a referral on the issue of description amendments
Read More
25
Jul
2023
Carpmaels & Ransford promotes four Senior Associates as of 1st July 2023
Senior Associate promotions further the Healthcare credentials of the firm
Read More
06
Jul
2023
IAM Patent 1000 rankings 2023
Carpmaels & Ransford is top ranked again for patent prosecution
Read More
27
Jun
2023
Managing IP EMEA Awards 2023
Carpmaels & Ransford awarded UK Patent Prosecution Firm of the Year at the Managing IP EMEA Awards 2023
Read More
22
Jun
2023
Financial Times: Europe’s Leading Patent Law Firms 2023
Carpmaels & Ransford listed again as one of Europe’s leading patent firms
Read More
14
Jun
2023
The UPC has now opened
A new era for European patent law – the biggest change in five decades
Read More
01
Jun
2023
Carpmaels in Conversation: Ep. 25 – Can an undisclosed disclaimer be used to restore a loss of partial priority?
Episode overview
Read More
23
May
2023
New certainty for handling of cases by the central division of the UPC
For the time being, UPC actions on many life science, pharmaceutical and medtech patents will be heard in Paris, with some cases to be heard in Munich
Read More
16
May
2023

Type

Service

Sector

Archive